pocketful logo light
pocketful logo light
Supriya Lifescience Ltd logo

Supriya Lifescience Ltd

NSE: SUPRIYA BSE: 543434

₹803.15

(0.61%)

Wed, 09 Sept 2026, 05:29 am

mtf coin illustrationMTF 5x

Supriya Lifescience Share Price Live Chart

1 Day

(0.61%)

No Result Found

Summary

  • Market Cap (in Cr)

    7796.37

  • Net Profit (in Cr)

    187.96

  • P/B

    5.92

  • Sector P/E

    44.89

  • P/E

    31.42

  • EV/EBITDA

    21.53

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    20.74

  • ROCE

    27.43

  • Debt/Equity

    0.01

  • EPS (TTM)

    26.03

  • Dividend Yield

    0.10

  • Book Value

    148.82

  • Interest Cover

    138.28

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters68.3068.3068.3068.3068.30
FII5.165.205.466.787.19
DII5.705.015.224.864.26
Public20.8421.5021.0220.0620.26
Government00000

Read More

Technical Analysis

RSI

63.88

MACD

11.05

50 DMA

850.23

200 DMA

759.22

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1251.021040.47919.38829.92708.83619.37408.82
Fibonacci1040.47960.04910.35829.92749.49699.80619.37
Camarilla856.20836.90817.60829.92779.00759.70740.40

Pivots Level: Classic

R3

+421.10

1251.02

R2

+210.55

1040.47

R1

+89.47

919.38

829.92
829.92
Pivot Point
LTP: 905.60

S1

-121.08

708.83

S2

-210.55

619.37

S3

-421.10

408.82

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    861.42

  • 20-EMA

    845.79

  • 30-EMA

    844.78

  • 50-EMA

    844.06

  • 100-EMA

    822.48

  • 200-EMA

    781.60

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
27 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
09 Feb 2026board-meetingsQuarterly Results
02 Sept 2025agm
05 Aug 2025dividendFinal Dividend - Rs. - 105 Sept 2025
04 Aug 2025dividendDividend - Re 1 Per Share05 Sept 2025
27 May 2025dividend₹1.00 Dividend /Share05 Sept 2025
13 Sept 2024agm
20 Aug 2024dividendAnnual General Meeting/Dividend - Rs 0.80 Per Share21 Sept 2024
28 May 2024dividend₹0.80 Dividend /Share21 Sept 2024
04 Sept 2023agm

Read More

Peer Comparison

Supriya Lifescience Ltd logo

Supriya Lifescience Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Supriya Lifescience Ltd About

Supriya Lifesciences is primarily engaged in manufacturing of Bulk Drugs and Pharmaceutical Chemicals.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2008

Headquarters

CEO

Satish Waman Wagh

Employees

Contact

Website icon

Website

http://www.supriyalifescience.com

Email icon

Email

cs@supriyalifescience.com

Phone icon

Phone

91-22-40332727

Location icon

Location

207/208 Udyog Bhavan, Sonawala Road Goregaon (East), Mumbai, Maharashtra, 400063

Read More

Supriya Lifescience Ltd Company History

YearHistory
2018
  • CEP (Certificate of Sustainability) was granted for Brompheniramine Maleate, Mepyramine Maleate and Ketamine Hydrochloride.
2020
  • Third time USFDA approval was granted.
2021
  • CEP (Certificate of Suitability) was granted for Pentoxifylline, Esketamine Hydrochloride and Salbutamol Sulphate.
  • NMPA approval was granted.
  • Health Canada approval was granted.
2022
  • Supriya Lifescience Limited signed a captive solar project agreement with Enrich Energy Pvt. Ltd.
2024
  • Supriya Lifescience Ltd inaugurated a state-of-the-art Module E production block at Lote Parshuram, Maharashtra.
  • Supriya Lifescience inaugurated a Rs 125 crore API production block at Lote Parshuram site.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkSell585068785.0222 Nov 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy585068784.7922 Nov 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy658285488.5912 Aug 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell658285488.6112 Aug 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell627793342.3208 Feb 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy627793342.2108 Feb 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy456665312.2626 Dec 2023
GRAVITON RESEARCH CAPITAL LLPbulkSell456665312.426 Dec 2023
GRAVITON RESEARCH CAPITAL LLPbulkSell403147248.4812 May 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy403147248.3812 May 2023

Read More

Supriya Lifescience Ltd News

Supriya Lifescience seeks shareholder nod for director re-appointment

Supriya Lifescience Ltd has initiated a postal ballot process for the re-appointment of Mr. Balasaheb Sawant as Whole Time Director. The voting period is open from July 23 to August 21, 2026.

21 Jul 2026

companies

Supriya Lifescience GM faces judicial custody

Supriya Lifescience Ltd. informed exchanges that its GM Sales & Marketing, Sreekant Sreedharan, was granted judicial custody till July 17, 2026, following an investigation by the Customs Department under the NDPS Act.

04 Jul 2026

companies

Supriya Lifescience promoters hold unencumbered shares in FY26

Promoters of Supriya Lifescience Limited disclosed no encumbrance of shares during FY ended March 31, 2026. The filing was made to BSE and NSE under SEBI takeover regulations.

29 Jun 2026

companies

Supriya Lifescience declares FY26 dividend

Supriya Lifescience recommended a final dividend of Re 1.00 per share for FY25-26. The dividend is subject to shareholder approval and TDS provisions.

23 Jun 2026

companies

Supriya Lifescience closes trading window from July 1

Supriya Lifescience Ltd. closed its trading window from July 1, 2026, until 48 hours after Q1FY27 results declaration.

20 Jun 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Supriya Lifescience Ltd?

    As of 09/09/2026 at 10:59 AM, Supriya Lifescience Ltd shares are trading at ₹803.15.

  • 2.What is the market cap. of Supriya Lifescience Ltd?

    As of 09/09/2026, the market capitalization of Supriya Lifescience Ltd is ₹6,433.79 crore.

  • 3.When was Supriya Lifescience Ltd founded?

    Supriya Lifescience Ltd was founded in 2008.

  • 4.What are the P/E and P/B ratios of Supriya Lifescience Ltd?

    As of 09/09/2026, Supriya Lifescience Ltd has a P/E ratio of 32.59 and a P/B ratio of 5.92.

  • 5.How can I buy shares of Supriya Lifescience Ltd?

    You can buy shares of Supriya Lifescience Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Supriya Lifescience Ltd?

    As of March,2026, promoters hold 68.30% in Supriya Lifescience Ltd, while FIIs, DIIs and public shareholders hold 5.16%, 5.70% and 20.84%, respectively.

  • 7.Does Supriya Lifescience Ltd pay dividends?

    Yes, Supriya Lifescience Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 1 per share.

  • 8.What is the dividend yield of Supriya Lifescience Ltd?

    As of 09 September, 2026, the dividend yield of Supriya Lifescience Ltd stands at 0.13%.

  • 9.What are the latest financial results of Supriya Lifescience Ltd?

    For January,2024, Supriya Lifescience Ltd reported revenue of ₹680.00 crore and a net profit of ₹188.00 crore.

  • 10.What is the Stock symbol of Supriya Lifescience Ltd?

    SUPRIYA is the stock symbol of Supriya Lifescience Ltd.

  • 11.Who is the CEO of Supriya Lifescience Ltd?

    The CEO of Supriya Lifescience Ltd is Satish Waman Wagh.

Open Your Free Demat Account

Enter your phone number